Send me a link:

*Text messaging rates may apply.

 Dow Up0.08% Nasdaq Down0.09%

Compugen Ltd. (CGEN)

8.75 Down 0.02(0.23%) 10:29AM EDT - Nasdaq Real Time Price
ProfileGet Profile for:
Compugen Ltd.
72 Pinchas Rosen Street
Tel Aviv, 69512
Israel - Map
Phone: 972 3 765 8585
Fax: 972 3 765 8555

Index Membership:N/A
Full Time Employees:57

Business Summary 

Compugen Ltd., a therapeutic product discovery company, is engaged in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates primarily in the United States, Europe, and Israel. It focuses on the therapeutic proteins and monoclonal antibodies to address unmet needs in the fields of immunology and oncology. The company’s therapeutic proteins pipeline includes CGEN-15001, CGEN-15021, CGEN-15091, CGEN-15031, and CGEN-15051 fusion protein candidates for the treatment of autoimmune diseases and inflammatory conditions, such as multiple sclerosis and rheumatoid arthritis. Its monoclonal antibody therapy product candidates include CGEN-15001T, CGEN-15022, and CGEN-15049; and CGEN-671, a novel antibody-drug conjugate. Compugen Ltd. was incorporated in 1993 and is headquartered in Tel Aviv, Israel.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Compugen Ltd.

Key Executives 
Dr. Anat Cohen-Dayag Ph.D., 47
Chief Exec. Officer, Pres and Director
Mr. Avihai Shen , 46
Interim Chief Financial Officer
Ms. Tami Fishman Jutkowitz , 38
Gen. Counsel
Tsipi Keren-Lehrer ,
VP of Bus. Devel.
Ms. Dorit Amitay , 46
VP of HR
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders